A multi-centre randomized, open-label phase II trial of continuous erlotinib plus gemcitabine or gemcitabine as first-line therapy in ECOG PS2 patients with advanced non-small cell lung cancer

By            

Oncology Reports, Vol. 28, Iss. 3, 2012-01 ,pp. : 763-767

Spandidos Publications

Access to resources Recommend Favorite

Combination of Cisplatin and Interferon- 2a (Roferon(R)-A) in Patients with Non-small Cell Lung Cancer (NSCLC). An Open Phase II Multicentre Study

By Kataja V.   Yap A.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 35-40

Elsevier

Access to resources Recommend Favorite

Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

By Kalmadi Sujith   McNeill Giles   Davis Mellar   Peereboom David   Adelstein David   Mekhail Tarek  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 507-513

Humana Press, Inc

Access to resources Recommend Favorite

Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer - report of a phase I/II dose-escalating study

By Thomas A.L.   Cox G.   Sharma R.A.   Steward W.P.   Shields F.   Jeyapalan K.   Muller S.   O'Byrne K.J.  

European Journal of Cancer, Vol. 36, Iss. 18, 2000-12 ,pp. : 2329-2334

Elsevier

Access to resources Recommend Favorite

The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: A phase II study

By Shen Hua   Li Xiao-Dong   Wu Chang-Ping   Yin Yong-Mei   Wang Rong-sheng   Shu Yong-Qian  

International Journal of Hyperthermia, Vol. 27, Iss. 1, 2011-02 ,pp. : 27-32

Informa Healthcare

Access to resources Recommend Favorite